Macquarie Group LTD Ginkgo Bioworks Holdings, Inc. Transaction History
Macquarie Group LTD
- $85.1 Billion
- Q2 2024
A detailed history of Macquarie Group LTD transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 52,425 shares of DNA stock, worth $424,118. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,425Holding current value
$424,118% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNA
# of Institutions
346Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.16 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.12 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.09 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$565 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$340 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.4B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...